MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced the expansion of its Board of Directors with the appointment of Steven Boyd and Keith Maher, M.D. Both Directors […]
Author: Ken Dropiewski
Paragonix Technologies Receives Coveted International Design Award for Novel Organ Transportation System
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced that its flagship product, Paragonix SherpaPak™ Cardiac Transport System (CTS), is the recipient of a prestigious international design award: the Red Dot Award. The traditional mechanism by which organs are transported (bagged on ice in a consumer cooler) has remained unchanged for more than […]
Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease
Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease FDA has agreed to key aspects of the clinical program, including the primary endpoint for the single pivotal phase 3 study There are approximately 175,000 and 150,000 ESKD patients with PAD […]
Shockwave Appoints Maria Sainz to Board of Directors
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that Maria Sainz has joined its Board of Directors and will serve on Shockwave’s Compensation Committee. “I am delighted […]
Windtree Appoints John Hamill as Chief Financial Officer
WARRINGTON, Pa., July 20, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced John Hamill has been appointed Senior Vice President, Chief Financial Officer. In this role, Mr. Hamill will […]
VectraCor and GS GmbH (Corpuls) Form Licensing Agreement to Incorporate VectraCor’s 22-Lead ECG and CEB® (Cardiac Electrical Biomarker) Technology in Corpuls Defibrillators
Both Companies Committed to Bringing the Best Cardiac Care to the Healthcare Workers and Patients that Need It TOTOWA, New Jersey, July 16, 2020 /PRNewswire/ — GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced today that they have concluded a licensing agreement allowing corpuls to incorporate VectraCor’s […]
LivaNova announces the commercial launch of the Perceval Plus aortic valve in Europe
Next generation sutureless surgical technology is based on a clinically proven platform and has been designed to provide valve durability LONDON – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leading medical technology and innovation company, announced today that the Perceval ® Plus Advanced Suture-Free Surgical Aortic Valve is now available for a commercial […]
Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition – A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence
New System Rounds Out CT Portfolio that Provides Clinicians with Innovative Cardiac Capabilities TUSTIN, Calif.–(BUSINESS WIRE)–To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition – the Aquilion ONE / GENESIS SP – a complete […]
PhaseBio Doses First Patient in VANGARD Phase 2 Clinical Trial to Evaluate PB1046 for Hospitalized COVID-19 Patients
Recently launched Phase 2 “VANGARD” trial to assess the efficacy and safety of PB1046 in hospitalized COVID-19 patients at high risk for rapid clinical deterioration and acute respiratory distress syndrome PB1046, a long-acting analog of vasoactive intestinal peptide (VIP), has the potential to modulate several proinflammatory cytokines that are believed […]
BioSig Technologies, Inc. Adopts Stockholder Rights Agreement
Westport, CT, July 16, 2020 (GLOBE NEWSWIRE) — Rights Agreement designed to assure stockholders receive fair and equal treatment in the event of any proposed takeover Provides a guard against tactics to gain control of the Company without paying stockholders a market premium for that control BioSig Technologies, Inc. (NASDAQ: […]


